Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.
Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A, Fruchart-Najib J, Holleran S, Cohn JS, Ramakrishnan R, et al.
J Clin Invest. 2005 May; 115(5):1323-32. Epub 2005 Apr 1.
[J Clin Invest. 2005]